|
|
(3 intermediate revisions not shown.) |
Line 1: |
Line 1: |
| | | |
| ==Antimicrobial peptide protegrin PG-5== | | ==Antimicrobial peptide protegrin PG-5== |
- | <StructureSection load='2nc7' size='340' side='right' caption='[[2nc7]], [[NMR_Ensembles_of_Models | 20 NMR models]]' scene=''> | + | <StructureSection load='2nc7' size='340' side='right'caption='[[2nc7]]' scene=''> |
| == Structural highlights == | | == Structural highlights == |
- | <table><tr><td colspan='2'>[[2nc7]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2NC7 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2NC7 FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[2nc7]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Sus_scrofa Sus scrofa]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2NC7 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2NC7 FirstGlance]. <br> |
- | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2nc7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2nc7 OCA], [http://pdbe.org/2nc7 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=2nc7 RCSB], [http://www.ebi.ac.uk/pdbsum/2nc7 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=2nc7 ProSAT]</span></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR, 20 models</td></tr> |
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2nc7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2nc7 OCA], [https://pdbe.org/2nc7 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2nc7 RCSB], [https://www.ebi.ac.uk/pdbsum/2nc7 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2nc7 ProSAT]</span></td></tr> |
| </table> | | </table> |
- | == Function == | |
- | [[http://www.uniprot.org/uniprot/PG5_PIG PG5_PIG]] Microbicidal activity. | |
| <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
| == Publication Abstract from PubMed == | | == Publication Abstract from PubMed == |
Line 17: |
Line 16: |
| </div> | | </div> |
| <div class="pdbe-citations 2nc7" style="background-color:#fffaf0;"></div> | | <div class="pdbe-citations 2nc7" style="background-color:#fffaf0;"></div> |
| + | |
| + | ==See Also== |
| + | *[[Protegrin|Protegrin]] |
| == References == | | == References == |
| <references/> | | <references/> |
| __TOC__ | | __TOC__ |
| </StructureSection> | | </StructureSection> |
- | [[Category: Aganov, A V]] | + | [[Category: Large Structures]] |
- | [[Category: Klochkov, V V]] | + | [[Category: Sus scrofa]] |
- | [[Category: Klochkova, E A]] | + | [[Category: Aganov AV]] |
- | [[Category: Kolosova, O A]] | + | [[Category: Klochkov VV]] |
- | [[Category: Antimicrobial peptide]] | + | [[Category: Klochkova EA]] |
- | [[Category: Antimicrobial protein]] | + | [[Category: Kolosova OA]] |
- | [[Category: Dpc micelle]]
| + | |
- | [[Category: Protegrin]]
| + | |
| Structural highlights
Publication Abstract from PubMed
Protegrin pore formation is believed to occur in a stepwise fashion that begins with a nonspecific peptide interaction with the negatively charged bacterial cell walls via hydrophobic and positively charged amphipathic surfaces. There are five known nature protegrins (PG1-PG5), and early studies of PG-1 (PDB ID:1PG1) shown that it could form antiparallel dimer in membrane mimicking environment which could be a first step for further oligomeric membrane pore formation. Later, we solved PG-2 (PDB ID:2MUH) and PG-3 (PDB ID:2MZ6) structures in the same environment and for PG-3 observed a strong dalphaalpha NOE effects between residues R18 and F12, V14, and V16. These "inconsistent" with monomer structure NOEs appears due to formation of an additional antiparallel beta-sheet between two monomers. It was also suggested that there is a possible association of protegrins dimers to form octameric or decameric beta-barrels in an oligomer state. In order to investigate a more detailed oligomerization process of protegrins, in the present article we report the monomer (PDB ID: 2NC7) and octamer pore structures of the protegrin-5 (PG-5) in the presence of DPC micelles studied by solution NMR spectroscopy. In contrast to PG-1, PG-2, and PG-3 studies, for PG-5 we observed not only dimer NOEs but also several additional NOEs between side chains, which allows us to calculate an octamer pore structure of PG-5 that was in good agreement with previous AFM and PMF data.
Oligomerization of the antimicrobial peptide Protegrin-5 in a membrane-mimicking environment. Structural studies by high-resolution NMR spectroscopy.,Usachev KS, Kolosova OA, Klochkova EA, Yulmetov AR, Aganov AV, Klochkov VV Eur Biophys J. 2017 Apr;46(3):293-300. doi: 10.1007/s00249-016-1167-5. Epub 2016 , Sep 2. PMID:27589857[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
See Also
References
- ↑ Usachev KS, Kolosova OA, Klochkova EA, Yulmetov AR, Aganov AV, Klochkov VV. Oligomerization of the antimicrobial peptide Protegrin-5 in a membrane-mimicking environment. Structural studies by high-resolution NMR spectroscopy. Eur Biophys J. 2017 Apr;46(3):293-300. doi: 10.1007/s00249-016-1167-5. Epub 2016 , Sep 2. PMID:27589857 doi:http://dx.doi.org/10.1007/s00249-016-1167-5
|